Caspases are universal effectors of apoptosis. The mitochondrial and death receptor pathways activate distinct apical caspases (caspase-9 and -8, respectively) that converge on the proteolytic activation of the downstream executioner caspase-3. Caspase-9 and -8 cleave procaspase-3 to produce a p24 processing intermediate (composed of its pro-domain and large subunit), which then undergoes autoproteolytic cleavage to remove the pro-domain from the active protease. Recently, several heat shock proteins have been shown to selectively inhibit the mitochondrial apoptotic pathway by disrupting the activation of caspase-9 downstream of cytochrome c release. We report here that the small heat shock protein αB-crystallin inhibits both the mitochondrial and death receptor pathways. In S-100 cytosolic extracts treated with cytochrome c/dATP or caspase-8, αB-crystallin inhibits the autoproteolytic maturation of the p24 partially processed caspase-3 intermediate. In contrast, neither the closely related small heat shock protein family member Hsp27 nor Hsp70 inhibited the maturation of the p24 intermediate.
Introduction
The caspase family of cysteine proteases are critical effectors of apoptosis that selectively cleave key proteins at aspartate residues, thereby altering their function to promote cell death (1, 2) . Caspases are synthesized as pro-enzymes that are activated by trans-or auto-proteolytic cleavage at aspartate residues. They are arranged in a proteolytic cascade with some acting as initiators (-8, -9 and -10) and others acting as downstream executioners (-3, -6 and-7). The apical caspases are activated by two principal mechanisms, the mitochondrial and death receptor pathways, that converge on the proteolytic activation of caspase-3. In the former pathway, mitochondria respond to a variety of stimuli including genotoxic stress by releasing cytochrome c into the cytosol (3) . Cytochrome c then binds to Apaf-1, which oligomerizes in the presence of ATP, and recruits/activates pro-caspase-9; this multimeric complex is often referred to as the apoptosome (4, 5) . In the death receptor pathway, members of the tumor necrosis factor (TNF) 1 -α family bind to their receptors, thereby recruiting and activating pro-caspase-8 via a series of protein-protein interactions mediated by FADD (6, 7) . Active caspase-9 (the mitochondrial pathway) or caspase-8 (the death receptor pathway) then initiate the proteolytic activation of procaspase-3 by a multi-step mechanism. In the first step, caspase-9 or -8 cleave pro-caspase-3 at an aspartate residue between its large and small subunits to generate a p24 intermediate (the prodomain and the large subunit) and the p12 small subunit (8) (9) (10) (11) (12) . Next, the pro-domain is removed from the p24 intermediate by an autoproteolytic event to generate the p20 and p17 forms of the large subunit (8) (9) (10) (11) (12) . Active caspase-3 (two p17/p12 heterodimers) then induces the cell to undergo apoptosis by proteolyzing key cellular targets.
Many of the stress stimuli that are capable of triggering apoptosis, such as oxidative stress and heat shock, induce the synthesis of diverse heat shock proteins (HSPs) that confer a protective effect against a wide range of cellular stresses. Recent evidence indicates that many
HSPs are anti-apoptotic and directly inhibit caspase activation. For instance, Hsp70 and Hsp90 bind to Apaf-1 and prevent the recruitment of pro-caspase-9 to the apoptosome, thereby inhibiting caspase-9 activation (13) (14) (15) . In contrast, Hsp27, a member of the small HSP family, has been shown to bind/sequester cytosolic cytochrome c from the apoptosome and prevent procaspase-9 activation (16 downstream of caspase-9 activation by binding to pro-caspase-3 and blocking its proteolytic activation (17) . These studies indicate that some HSPs, and presumably others, confer resistance to apoptosis by specifically inhibiting one or more components of the apoptotic machinery.
In the present report, we examined the anti-apoptotic mechanisms of αB-crystallin, a small HSP family member related to Hsp27. Members of the small HSP family contain a highly conserved α−crystallin domain that is flanked by largely divergent amino-and carboxy-terminal domains (18) . They form oligomeric complexes that function as molecular chaperones to facilitate protein folding and prevent aggregation of denatured or misfolded proteins (18) . αB-crystallin is constitutively expressed in many tissues, and it is particularly abundant in the lens, heart, skeletal muscle and in some cancers (18, 19) . The expression of αB-crystallin is also induced by diverse cellular stresses (20) . Moreover, αB-crystallin has been shown to protect cells against apoptosis induced by DNA damaging agents, TNF-α, and Fas (21, 22 
Construction of FLAG-tagged cDNAs:
The full-length αB-crystallin cDNA was PCR-amplified from human αB-crystallin cDNA with the following oligonucleotide primers: 5'-GGCCGAA-TTCATGGACATCGCCATCCACCAC-3' and 5'-GGCCCTCGAGCTATTTCTTGGGGGCTG-CGG-3'. The full-length Hsp27 cDNA was PCR-amplified from human heart cDNA (Clontech) using the following primers: 5'-GGCCGAATTCATGACCGAGCGCCGCGT-CCC-3' and 5'-GGCCCTCGAGTTACTTGGCGGCAGTCTCCATC-3'. The PCR products were then digested with EcoRI and XhoI and cloned into a modified pcDNA3 vector in which the FLAG epitope was inserted upstream of the multiple cloning site (kindly provided by Dr. J. Settleman).
Sequences were confirmed by automated DNA sequencing. pcDNA3-FLAG-αB-crystallin and allowed to recover for 48 h; clones stably expressing these constructs were then selected by growth in 800 µg/ml G418 (Life Technologies) for 3 weeks.
Transient and Stable
Individual G418-resistant clones were examined for expression of αB-crystallin by immunoblotting with FLAG M2 mAb (Sigma) as described (23) . http://www.jbc.org/ Downloaded from described previously (24) . Apoptosis was scored as the percentage of transfected cells that had condensed/fragmented nuclei by staining with Hoescht #33258 (Sigma) as described (24 Caspases were activated by the addition of 1 µg cytochrome c (Sigma)/1 mM dATP (Pharmacia) for 30 min at 37°C or 30 ng of recombinant caspase-8 for 45 min at 37°C. The reaction products were resolved by SDS-PAGE and visualized by autoradiography as described (23, 25) . The procaspase-3 and pro-caspase-7 activation studies were performed as above except that 35 S-labeled pro-caspase-9 was omitted, and the reaction products were analyzed by immunoblotting with caspase-3 mAb (Transduction Laboratories) or caspase-7 mAb (Pharmingen) (23) .
Induction and Analysis of Apoptosis
Immunoprecipitation: MDA-MB-231 cells stably expressing FLAG-vector or FLAG-αB-crystallin were lysed in IP lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 5% glycerol) at a final concentration of 1x10 6 cells/ml, and incubated on ice for 30 min.
Lysates were then centrifuged at 12000 rpm at 4°C for 15 min. The supernatant was incubated with Protein A agarose beads (Sigma) and 2 µg of anti-IgG (Sigma) or anti-FLAG (Sigma) polyclonal antibodies. Complexes were immunoprecipitated overnight at 4°C. Beads were then washed four times in IP wash buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EDTA, 100 mM NaF) and the immunoprecipated proteins were detected by immunoblotting with αB-crystallin mAb (StressGen Biotechnologies) or caspase-3 mAb as described (23) .
by guest on September 1, 2017
http://www.jbc.org/
Downloaded from

Results
B-Crystallin Inhibits Etoposide-and TNF--Induced Apoptosis
To begin delineating the mechanisms by which αB-crystallin inhibits apoptosis, we a small HSP family member closely related to αB-crystallin, also conferred a similar degree of protection against etoposide-and TNF-α-induced apoptosis. We also generated MDA-MB-231
clones stably expressing FLAG-tagged αB-crystallin. As shown in Fig. 1B , the A5 and B4
clones stably expressing αB-crystallin were also protected against apoptosis induced by etoposide and TNF-α compared with pooled, FLAG vector-transfected cells. These findings demonstrate unequivocally that αB-crystallin inhibits both the mitochondrial and death receptor apoptotic pathways. In addition, because these two pathways converge on the proteolytic activation of pro-caspase-3, they suggest that αB-crystallin may negatively regulate apoptosis by inhibiting caspase-3 activation and/or other downstream events shared by both pathways.
B-Crystallin Inhibits the Autoproteolytic Maturation of the p24 Partially Processed Caspase-3
We first examined the ability of recombinant αB-crystallin to inhibit the cytochrome cdependent activation of pro-caspase-9 and pro-caspase-3 in Jurkat S-100 cytosolic extracts.
Importantly, the range of concentrations of αB-crystallin (2-15 µM) used are consistent with those observed in a variety of cancer cell lines, either constitutively or in response to heat shock (M. Kamradt and V. Cryns, unpublished data). As shown in Fig. 2A (upper crystallin (even at 15 µM concentration) only weakly inhibited the proteolytic processing of procaspase-9 compared to Hsp27 (15 µM) and Hsp70 (5 µM); the latter observation is consistent with the reported ability of Hsp27 and Hsp70 to disrupt apoptosome assembly and prevent procaspase-9 activation (13, 15, 16) . As demonstrated in Fig. 2A (middle panel) , the addition of cytochrome c and dATP to S-100 extracts also triggered the cleavage of pro-caspase-3 into its p20 and p17 forms of the large subunit (indicated by arrows); the caspase-3 mAb used in these studies does not detect the small p12 subunit. However, the addition of αB-crystallin led to the dose-dependent accumulation of the p24 partially processed caspase-3 (pro-domain plus the large subunit) with a corresponding reduction in the amount of fully processed caspase-3, particularly p17. The p24 processing intermediate was observed at concentrations of αB-crystallin as low as 2 µM (on prolonged exposure of the immunoblot, data not shown). Because αB-crystallin is similar in size to the p24 partially processed caspase-3, we demonstrated that the caspase-3 mAb does not cross-react with αB-crystallin (Fig. 2C) . The functional relevance of the caspase-3 maturation defect caused by αB-crystallin is demonstrated by αB-crystallin's dosedependent reduction in the proteolytic processing of pro-caspase-7 ( Fig. 2A, lower these findings indicate that the principal mechanism by which αB-crystallin inhibits the cytochrome c-dependent activation of caspase-3 is by blocking its autoproteolytic maturation.
We next examined whether αB-crystallin inhibited the caspase-8-dependent activation of pro-caspase-3 in S-100 extracts. In this system, pro-caspase-3 is directly cleaved by caspase-8 to generate the p24 intermediate, and the pro-domain is subsequently removed by autoproteolytic cleavage to produce the p20/p17 forms of the large subunit (8) (9) (10) (11) (12) . As demonstrated in hence, caspase-3 activation is not necessary for pro-caspase-7 processing in this system (8) .
Taken together, these observations indicate that αB-crystallin negatively regulates the cytochrome c-and caspase-8-dependent activation of caspase-3 by inhibiting the autoproteolytic maturation of its p24 intermediate.
B-Crystallin Binds to the p24 Partially Processed Caspase-3 In Vivo
To determine whether αB-crystallin binds to caspase-3 in vivo, we immunoprecipitated αB-crystallin from cells stably expressing FLAG-tagged αB-crystallin. Whole cell lysates derived from FLAG-vector or FLAG-αB-crystallin expressing cells were immunoprecipitated with FLAG mAb. As shown in Fig. 3 (middle panel), αB-crystallin co-immunoprecipitated with the p24 partially processed caspase-3 (indicated by arrow) in cells stably expressing FLAGtagged αB-crystallin; this interaction was not observed in FLAG-vector transfected cells.
Importantly, the caspase-3 processing intermediate that co-immunoprecipitated with αB-crystallin is the identical size as the p24 partially processed caspase-3 observed in cytosolic extracts treated with cytochrome c/dATP or caspase-8 in the presence of αB-crystallin (data not shown). Although the p24 intermediate is far less abundant than pro-caspase-3 in whole cell lysates (Fig. 3, lower panel) , it abundantly co-immunoprecipitated with αB-crystallin in the absence of any detectable interaction between αB-crystallin and pro-caspase-3, thereby underscoring the specificity of the interaction between αB-crystallin and partially processed caspase-3 in vivo. These findings suggest that αB-crystallin antagonizes the autocatalytic processing of caspase-3 by binding to and inhibiting the partially processed protease.
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Discussion
Recent studies indicate that several HSPs inhibit the mitochondrial apoptotic pathway by specifically binding to components of the cell death apparatus and disrupting the assembly of the apoptosome. Hsp70 and Hsp90 bind to Apaf-1, while Hsp27 binds to cytochrome c, to prevent the cytochrome c-mediated oligomerization of Apaf-1 and subsequent activation of pro-caspase-9 (13-16). We demonstrate here that the small HSP αB-crystallin inhibits both the mitochondrial and death receptor apoptotic pathways by a novel mechanism: αB-crystallin binds to caspase-3 that has been partially processed by caspase-9 or caspase-8 cleavage (p24) and inhibits the autoproteolytic removal of its pro-domain to produce its large subunit. Because this autocatalytic maturation is required for caspase-3 activation by both the mitochondrial and death receptor pathways, the inhibition of caspase-3 maturation by αB-crystallin is a parsimonious strategy to inhibit both pathways. In contrast, Hsp70 inhibits only the mitochondrial pathway and may even sensitize cells to Fas-induced apoptosis (13, 15, 27) . Importantly, neither Hsp27 nor Hsp70 had any effect on the autoproteolytic maturation of caspase-3. These observations indicate unambiguously that αB-crystallin inhibits apoptosis by a novel mechanism that is distinct from that of other HSPs examined to date.
Interestingly, the autoproteolytic maturation of capase-3 is also inhibited by the conserved IAP family member XIAP. Like αB-crystallin, XIAP does not inhibit the initial cleavage of pro-caspase-3 by caspase-8 in cytosolic extracts, but it binds to the p24 partially processed caspase-3 and inhibits its autoproteolytic maturation (12) . Although αB-crystallin is less potent in this respect, its inhibition of caspase-3's autoproteolytic maturation is observed at physiologically relevant concentrations (2-15 µM) as determined by quantitation of αB-crystallin levels in cancer cell lines (M. Kamradt and V. Cryns, unpublished data). Indeed, we have likely underestimated the concentration of αB-crystallin in some tissues. For instance, α-crystallin (a protein composed of αB-crystallin and αA-crystallin) accounts for 40% of the soluble protein in the lens, and αB-crystallin constitutes as much as 5% of the total protein in striated muscle (18, 19) . However, XIAP is also a potent inhibitor/substrate of active caspases-3 and -7 (12, 26) while αB-crystallin is not cleaved by caspases (data not presented). Hence, the molecular mechanism by guest on September 1, 2017
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Somewhat unexpectedly, the small HSP family members αB-crystallin and Hsp27 inhibit apoptosis by largely distinct mechanisms. In our studies, Hsp27 clearly disrupts the cytochrome c-dependent activation of pro-caspase-9, as others have reported (16), while αB-crystallin only weakly inhibits this event. Moreover, Hsp27 does not inhibit the autoproteolytic maturation of caspase-3. Although αB-crystallin and Hsp27 share approximately 40% amino acid identity, most of the identical residues are found within their respective α-crystallin domains; the amino-and carboxy-termini are largely divergent (18) . Hence, the different antiapoptotic mechanisms of these closely related small HSPs are likely to be the result of their distinct amino-and/or carboxy-termini. Although we and others (21, 22) have observed that
Hsp27, like αB-crystallin, inhibits both the mitochondrial and death receptor apoptotic pathways, the mechanism(s) by which Hsp27 inhibits the latter is unclear. In our studies, Hsp27 did not inhibit the caspase-8-dependent activation of pro-caspase-3, suggesting that Hsp27 inhibits death receptor apoptosis upstream of this step (perhaps by interfering with pro-caspase-8 activation).
Nevertheless, our findings provide unequivocal evidence that αB-crystallin and Hsp27 inhibit apoptosis by distinct mechanisms.
In contrast to αB-crystallin, two other HSPs have been shown to promote, rather than inhibit, caspase-3 maturation (28, 29) . Hsp60, Hsp10 and pro-caspase-3 form a multimeric complex in the mitochondria of intact cells. In cytosolic extracts, Hsp60 and Hsp10 promote the proteolytic activation of pro-caspase-3 by caspase-8 and -9 in an ATP-dependent fashion, suggesting that their chaperone activity enhances the sensitivity of pro-caspase-3 to proteolytic cleavage by apical caspases. Together with our observation that αB-crystallin inhibits the autocatalytic maturation of caspase-3, these findings indicate that the proteolytic maturation of caspase-3 is an exquisitely regulated event.
In short, αB-crystallin is a novel negative regulator of apoptosis that acts distally in the Although oligomerization of Hsp27 is necessary for its anti-apoptotic actions (33), the role of oligomerization in αB-crystallin's anti-apoptotic actions has not been studied. These and other issues will be examined in future studies using mutants of αB-crystallin that are impaired in one or more of these biochemical properties. 
